HealthQuill License
Nvidia has invested $50 million in a clinical-stage biotechnology company, Recursion, to speed up the development of artificial intelligence models for drug recovery and may later license them, according to a statement.
Drugs Health Pharma

Nvidia invests $50 million in Recursion to hasten AI drug recovery

HQ Team July 12, 2023: Nvidia has invested $50 million in a clinical-stage biotechnology company, Recursion, to speed up the development of artificial.

Read More
X